Login / Signup

A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission.

Anas GremidaParakkal Deepak
Published in: Crohn's & colitis 360 (2021)
Keyphrases
  • ulcerative colitis
  • disease activity
  • systemic lupus erythematosus
  • adverse drug
  • drug induced